Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Prediction of cardiovascular complications and progression of renal failure in pediatric patients with chronic kidney disease according to NKF-K/DOQI (2002) and KDIGO (2012) classifications
https://doi.org/10.21508/1027-4065-2022-67-2-12-19
Abstract
Chronic kidney disease in pediatric and adult patients is an overarching global problem. Stratification of chronic kidney disease C1–5 severity by classifications of the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) (2002) and Kidney Disease: Improving Global Outcomes (KDIGO) (2012) carried out in pediatric patients over the age of 2 years old, taking into account the low glomerular filtration rate at the age of 0 to 2 years. Differences were found in the prognosis of cardiovascular complications and the progression of renal failure in adult patients with chronic kidney disease at stages С3а and C3b according to KDIGO (2012). The literature data demonstrate different risks of cardiovascular complications and progression of renal functions by stages of chronic kidney disease in accordance with the NKF-K/DOQI (2002) and KDIGO (2012) classifications in pediatric patients. The results indicate that children with chronic kidney disease in the pre-dialysis stages C2–4 form a high-risk group, while those on C4–5 dialysis form a group of very high risk of cardiovascular complications.
About the Authors
N. D. Savenkova
Saint Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint Petersburg
O. P. Grigorieva
Saint Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint Petersburg
References
1. World Kidney Day. https://www.worldkidneyday.org. Ссылка активна на 01.02.2022.
2. Collins A.J, Couser W. G., Dircs J.H, Kopple J.D., Reiser T., Rielia M.C. et al. International Federation of Kidney Foundations, International Society of Nephrology. World Kidney Day: An Idea Whose Time Has Come. Kidney Int 2006; 69: 781–782. DOI: 10,1038/sj.ki/https World Kidney Day
3. K/DOQI Kidney Disease Outcomes Quality Initiative. Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification Stratification. Am J Kidney Dis (AJKD) 2002; 39(2) Suppl. 1: 1–266. DOI: 10,1016/S0272–6386(02)701–77
4. Hogg R.J., Furth S., Lemley K.V., Portman R., Schwartz G.J., Coresh J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification and stratification. Pediatrics 2003; 111(6): 1416–1421. DOI: 10,1542/peds.111,6.1416
5. Schwartz G.J., Haycock G.B., Edelmann C.M., Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58(2): 259–263
6. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescent. Pediatr Clin North Am 1987; 34(3): 571–590. DOI: 10,1016/s0031–3955(16)36251–4
7. Laglois V. Laboratory Evolution at Different Ages. In: D.F. Geary, F. Schaefer (eds). Comprehensive pediatric nephrology. Philadelphia: Mosby Elsevier, 2008; 39–54
8. Smirnov A.V., Dobrobravov V.A., Kayukov I.G., Kucher A.G., Tugusheva F.A., Trofimenko I.I. et al. Recommendations of the Research institute of nephrology of St. Petersburg medical university named after I.P.Pavlov: definition, classification, diagnostics and main trends of prophylactics of chronic kidney disease in adults. Saint-Petersburg: Levsha, 2008; 51. (in Russ.) DOI: 10,24884/1561–6274–2008–12–2–75–93
9. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice guideline for the evaluation and management of Chronic Kidney Disease. Kidney Int. 2013; Suppl 3: 1–150. DOI: 10,1038/kisup.2012,73
10. Clinical recommendations. Chronic kidney disease (CKD). Nefrologiya 2021; 25(5): 10–82. (in Russ.)
11. Smirnov A.V., Sedov V.M., Od-Erdene L., Kayukov I.G., Dobronravov V.A., Panina I.Yu. Reduction of the glomerular filtration rate as an independent risk factor of the cardio-vascular disease. Nefrologiya 2006; 10(4): 7–17. (in Russ.) DOI: 10.24884/1561–6274–2006–10–4–7–17
12. Lilien M.R., Groothoff J.W. Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 2009; 5(4): 229–235. DOI: 10,1038/nrneph.2009,10
13. Mitsnefes M.M. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol (JASN) 2012; 23(4): 578–585. DOI: 10,1681/ASN.2011111115
14. Haddad M.N., Winnicki E., Nguyen S. Editors. Adolescents with Chronic Kidney Disease from Diagnosis to End-Stage Disease. Springer. 2019; 283 DOI: 10,1007/978–3–319–97220–6
15. Weaver D.J., Mitsnefes M.M. Cardiovascular disease in children and adolescents with chronic kidney disease. Semin Nephrol 2018; 38(6): 559–569. DOI: 10,1016/j.semnephrol.2018.08.002
16. Mitsnefes M.M., Betoco A., Schneider M.F., Salusky I.B., Wolf M.S., Jüppner H. et al. FGF23 and left ventricular hypertrophy in children with CKD. Clin J Am Soc Nephrol 2018; 13(1): 45–52. DOI: 10,2215/CJN.02110217
17. Mohammed A.G.M., Gafar H.S., Elmalah A.A., Elhady M., Abd Elgalil H.M., Bayoumy E.S.M. Cardiac Biomarkers and Cardiovascular Outcome in Children with Chronic Kidney Disease. Iran J Kidney Dis 2019; 13(2): 120–128
18. Querfeld U., Schaefer F. Cardiovascular risk factors in children on dialysis: an update. Pediatr Nephrol 2020; 35(1): 41–57. DOI: 10,1007/s00467–018–4125-x
19. Khandelwal P., Murugan V., Hari S., Lakshmy R., Sinha A., Hari P. et al. Dyslipidemia, carotid intima–media thickness and endothelial dysfunction in children with chronic kidney disease. Pediatr Nephrol 2016; 31: 1313–1320. DOI: 10,1007/s00467–016–3350–4
20. Holle J., Querfeld U., Kirchner M., Anninos A., Okun J., Thurn-Valsassina D. et al. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease. Pediatr Nephrol 2019; 34: 2571–2582. DOI: 10,1007/s00467–019–04331–6
21. Doyon A., Mitsnefes M.M. Cardiovascular disease in pediatric chronic kidney disease. In: Pediatric Kidney Disease. Eds.: Geary DF, Schaefer F. 2nd ed. Berlin-Heidelberg: Springer-Verlag, 2016; 1567–1603. DOI: 10,1007/978–3–662–52972–0
22. Mitsnefes M.M. Cardiovascular disease. In: Pediatric Dialysis Case Studies. A Practical Guide to Patient Care. Eds.: Warady B.A, Schaefer F., Alexander S.R. Springer International Publishing AG. 2017; 209–213. DOI: 10,1007/978–3–319–55147–0_27
23. Karimdzhanov I.A., Iskanova G.K., Israilova N.A. Chronic kidney disease in children: problems of arterial hypertension. Nefrologiya 2019; 23(5): 47–55. (in Russ.)
24. Zeltyn-Abramov E.M., Frolova N.F. Hypertension and chronic kidney disease: from initial to advanced stages. Diagnostic and therapeutic strategies. Part 1. Arterial hypertension in patients with CKD stages 1–4. Nefrologiya i dializ 2020; 22(2): 221–236. (in Russ.) DOI: 10,28996/2618–9801–2020–2–221–236
25. Zeltyn-Abramov E.M., Frolova N.F. Hypertension and chronic kidney disease: from initial to advanced stages. Diagnostic and therapeutic strategies. Part 2. Renal replacement therapy (maintenance hemodialysis). Nefrologiya i dializ 2020; 22(2): 237–251. (in Russ.) DOI: 10,28996/2618–9801–2020–2–237–251
26. Therapy of arterial hypertension in children with chronic kidney disease: National guidelines. Editors M.E. Aksenova, V.V. Dlin. M.: Overlay, 2017; 54 (in Russ.)
27. Turakhia M.P., Blankestijn P.D., Carrero Kh., Clase C.M., Deo R., Herzog C.A. et al. Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Nefrologiya 2019; 23(2): 18–40. (in Russ.) DOI: 10,24884/1561–6274–2019–23–2–18–40
28. Sanderson K.R., Warady B.A. End-stage kidney disease in infancy: an educational review. Pediatr Nephrol 2020; 35(2): 229–240. DOI: 10,1007/s00467–018–4151–8
29. Vatazin A.V., Zulkarnaev A.B. Endotoxin and chronic inflammation in patients with chronic kidney disease. Nefrologiya 2016; 20(6): 26–32. (in Russ.)
30. Schnaper H.W. Pathophysiology of Progressive Renal Disease in Children. Pediatric Nephrology. Eds: Avner E.D., Harmon W.E., Niaudet P., Yoshikawa N. 7 Completely Revised, Updated and Enlarged Edition. Berlin-Heidelberg: Springer-Verlag, 2016; Vol 2: 2171–2206. DOI: 10,1007/978–3–662–43596–0_58
31. VanDeVoorde R., Warady B.A. Management of Chronic Kidney Disease. Pediatric Nephrology. Eds: E.D. Avner, W.E. Harmon, P. Niaudet, N. Yoshikawa. 7 Completely Revised, Updated and Enlarged Edition. Berlin-Heidelberg: Springer-Verlag, 2016; Vol 2: 2208–2251. DOI: 10,1007/978–3–540–76341–3_68
32. Vyalkova A.A., Zorin I.V., Chesnokova S.A., Plotnikova S.V. Chronic kidney disease in children. Nefrologiya 2019; 23(5): 29–46. (in Russ.) DOI: 10,24884/1561–6274–2019–23–5–29–46
33. Nastausheva N.S., Stakhurlova L.I., Zhdanova O.A., Chichuga E.M., Zvyagina T.G., Nastausheva T.L. et al. Physical development in children with chronic kidney disease (CKD). Nefrologiya 2015; 19(3): 32–38. (in Russ.)
34. Lysova E.V., Savenkova N.D. CAKUT-syndrome in the etiological structure of chronic kidney disease in children and adolescents. Nefrologiya 2017; 21(3): 69–74. (in Russ.) DOI: 10,24884/1561–6274–2017–3–69–74
35. Savenkova N.D. Classification perfection of acute kidney injury and chronic kidney disease in рediatric nephrology. Nefrologiya 2018; 22(3): 11–17. (in Russ.) DOI: 10,24884/1561–6274–2018–22–3–11–17
36. Komarova O., Tsygin A., Namazova-Baranova L., Baranov A. The rate of different etiology chronic kidney disease progression in children. Nefrologiya 2016; 20(2): 53–58. (in Russ.)
37. Leonteva E.V., Savenkova N.D. Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease. Rossiyskiy Vestnik Perinatologii i Pediatrii 2020; 65(1): 77–85. (in Russ.) DOI: 10,21508/1027–4065–2020–65–1–77–85
38. Makarova T.P., Melnikova Yu.S. Echocardiographic parameters of the heart with chronic kidney disease in children and adolescents. Rossiyskiy Vestnik Perinatologii i Pediatrii 2017; 62(5): 149– 152. (in Russ.) DOI: 10,21508/1027–4065–2017–62–5–149–152
39. ESPN/ERA-EDTA Registry An update on the Registry-January 2021. https://www.espn-reg.org/files/AR2018.pdf Cсылка активна на 09.01.2022.
40. ESPN/ERA-EDTA Registry The annual report including 2017 pediatric data http://www.espn-reg.org Cсылка активна на 09.01.2022.
41. Weaver D.J. Jr, Somers M.J.G., Martz K., Mitsnefes M.M. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol 2017; 32(12): 2319–2330. DOI: 10,1007/s00467–017–3759–4
42. Ignatova M.S., Lebedenkova M.V. Chronic kidney disease. Pediatric Nephrology: A Guide for Physicians. Ed. M.S. Ignatova. 3rd ed. revised and add. Moscow: Meditsinskoe informatsionnoe agentstvo. 2011; 529–542 (in Russ.)
43. Baiko S.V. Chronic kidney disease in children: definition, classification and diagnosis. Nefrologija i dializ 2020; 22(1): 53–70. (in Russ.) DOI: 10,28996/2618–9801–2020–1–53–70
44. Prikaz 712-n ot 20 noiabria 2018 g Ob utverzhdenii professionalnogo standarta Vrach nefrolog Ministerstva Truda i sotsialnoi zashchity RF (in Russ). https://minjust.consultant.ru/documents/41165 Cсылка активна 13.02.2022.
Review
For citations:
Savenkova N.D., Grigorieva O.P. Prediction of cardiovascular complications and progression of renal failure in pediatric patients with chronic kidney disease according to NKF-K/DOQI (2002) and KDIGO (2012) classifications. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(2):12-19. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-2-12-19
Views:
439
Email this article 